Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Sep 11, 16:00
Silence Therapeutics Price : 4.00 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 10, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 09, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 08, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 04, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 03, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 02, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 01, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 31, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 28, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 27, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 60.00 |
| Aug 26, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 25, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 40.00 |
| Aug 24, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 2000.00 |
| Aug 21, 2026 | 5.50 | 5.50 | 5.50 | 5.50 | 0.000 |
| Aug 20, 2026 | 5.50 | 5.50 | 5.50 | 5.50 | 0.000 |
| Aug 19, 2026 | 5.50 | 5.50 | 5.50 | 5.50 | 0.000 |
| Aug 18, 2026 | 5.50 | 5.50 | 5.50 | 5.50 | 550.00 |
| Aug 17, 2026 | 5.99 | 5.99 | 5.99 | 5.99 | 214.00 |
| Aug 14, 2026 | 5.99 | 5.99 | 5.99 | 5.99 | 0.000 |
| Aug 13, 2026 | 5.99 | 5.99 | 5.99 | 5.99 | 0.000 |
| Aug 12, 2026 | 5.99 | 5.99 | 4.40 | 5.99 | 1021.00 |
| Aug 11, 2026 | 4.575 | 4.575 | 4.575 | 4.575 | 350.00 |
| Aug 10, 2026 | 3.96 | 4.50 | 3.96 | 4.50 | 700.00 |
| Aug 07, 2026 | 1.50 | 1.50 | 1.50 | 1.50 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 1.30 |
| NuCana Plc | 1.32 |
| Mereo BioPharma Group Plc | 0.28 |
| Compass Pathways Plc | 14.35 |
| HemoGenyx Pharmaceuticals Plc | 2.33 |
Price Related Metrics
| PS Ratio | 921.65 |
| Price to Book Value | 14.74 |
| Earnings Yield | -10.58% |
| Market Cap | 566.96M |